| Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL W Ding, BR LaPlant, TG Call, SA Parikh, JF Leis, R He, TD Shanafelt, ... Blood, The Journal of the American Society of Hematology 129 (26), 3419-3427, 2017 | 423 | 2017 |
| Clinical and biological significance of RAS mutations in multiple myeloma WJ Chng, N Gonzalez-Paz, T Price-Troska, S Jacobus, SV Rajkumar, ... Leukemia 22 (12), 2280-2284, 2008 | 209 | 2008 |
| Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience P Kapoor, PT Greipp, EW Schaefer, SJ Mandrekar, AH Kamal, ... Mayo Clinic Proceedings 85 (10), 905-912, 2010 | 200 | 2010 |
| DNAJB1-PRKACA is specific for fibrolamellar carcinoma RP Graham, L Jin, DL Knutson, SM Kloft-Nelson, PT Greipp, ... Modern pathology 28 (6), 822-829, 2015 | 168 | 2015 |
| Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines 2016 P Kapoor, SM Ansell, R Fonseca, A Chanan-Khan, RA Kyle, SK Kumar, ... JAMA oncology 3 (9), 1257-1265, 2017 | 138 | 2017 |
| Anti‐CD20 monoclonal antibody therapy in multiple myeloma P Kapoor, PT Greipp, WG Morice, SV Rajkumar, TE Witzig, PR Greipp British journal of haematology 141 (2), 135-148, 2008 | 126 | 2008 |
| Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma RL Boddicker, GL Razidlo, S Dasari, Y Zeng, G Hu, RA Knudson, ... Blood, The Journal of the American Society of Hematology 128 (9), 1234-1245, 2016 | 124 | 2016 |
| Gastroblastoma harbors a recurrent somatic MALAT1–GLI1 fusion gene RP Graham, AA Nair, JI Davila, L Jin, J Jen, WR Sukov, TT Wu, ... Modern Pathology 30 (10), 1443-1452, 2017 | 104 | 2017 |
| Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response N Abdallah, SV Rajkumar, P Greipp, P Kapoor, MA Gertz, A Dispenzieri, ... Blood cancer journal 10 (8), 82, 2020 | 97 | 2020 |
| Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma M Binder, SV Rajkumar, RP Ketterling, PT Greipp, A Dispenzieri, MQ Lacy, ... Blood cancer journal 7 (9), e600-e600, 2017 | 93 | 2017 |
| Recurrent STAT3-JAK2 fusions in indolent T-cell lymphoproliferative disorder of the gastrointestinal tract A Sharma, N Oishi, RL Boddicker, G Hu, HK Benson, RP Ketterling, ... Blood, The Journal of the American Society of Hematology 131 (20), 2262-2266, 2018 | 88 | 2018 |
| Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein Y Wang, X Ding, S Wang, CD Moser, HM Shaleh, EA Mohamed, ... Cancer letters 380 (1), 163-173, 2016 | 88 | 2016 |
| Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors W Li, SK Gupta, W Han, RA Kundson, S Nelson, D Knutson, PT Greipp, ... Journal of Hematology & Oncology 12, 1-13, 2019 | 87 | 2019 |
| Molecular cytogenetic analysis for TFE3 rearrangement in Xp11. 2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases JC Hodge, KE Pearce, X Wang, AE Wiktor, AM Oliveira, PT Greipp Modern Pathology 27 (1), 113-127, 2014 | 76 | 2014 |
| Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities N Abdallah, P Greipp, P Kapoor, MA Gertz, A Dispenzieri, LB Baughn, ... Blood Advances 4 (15), 3509-3519, 2020 | 71 | 2020 |
| Molecular testing for the clinical diagnosis of fibrolamellar carcinoma RP Graham, MM Yeh, D Lam-Himlin, LR Roberts, L Terracciano, ... Modern pathology 31 (1), 141-149, 2018 | 64 | 2018 |
| Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1‐PRKACA fusion RP Graham, C Lackner, L Terracciano, Y González‐Cantú, ... Hepatology 68 (4), 1441-1447, 2018 | 59 | 2018 |
| A simple additive staging system for newly diagnosed multiple myeloma NH Abdallah, M Binder, SV Rajkumar, PT Greipp, P Kapoor, A Dispenzieri, ... Blood cancer journal 12 (1), 21, 2022 | 56 | 2022 |
| Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations RL King, WI Gonsalves, SM Ansell, PT Greipp, LA Frederick, ... American journal of clinical pathology 145 (6), 843-851, 2016 | 56 | 2016 |
| IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features S Sidana, DP Larson, PT Greipp, R He, ED McPhail, A Dispenzieri, ... Leukemia 34 (5), 1373-1382, 2020 | 52 | 2020 |
